Silent mutations in coding regions of Hepatitis C virus affect patterns of HCV RNA structures and attenuate viral replication and pathogenesis. [PDF]
Dabour R +6 more
europepmc +1 more source
The prevalence of HCV RNA positivity in anti-HCV antibodies-negative hemodialysis patients in Thrace Region. Multicentral study. [PDF]
Konstantinidou EI +17 more
europepmc +1 more source
ABSTRACT Hepatitis A virus (HAV) infection is an uncommon indication for liver transplantation, and donor‐derived or transfusion‐associated HAV infection is rare. Data describing HAV recurrence or early acquisition following liver transplantation, particularly with longitudinal quantitative viral kinetics, are limited.
David Mutimer +3 more
wiley +1 more source
N6-methyladenosine modification of HCV RNA genome regulates cap-independent IRES-mediated translation via YTHDC2 recognition. [PDF]
Kim GW, Siddiqui A.
europepmc +1 more source
ABSTRACT The introduction of potent, well‐tolerated direct‐acting antivirals (DAAs) has transformed hepatitis C virus (HCV) therapy and spurred global elimination efforts. However, the extensive genetic diversity of HCV may affect antiviral efficacy, particularly in low and middle‐income regions where limited data currently exist.
Win Min Han +11 more
wiley +1 more source
Analytical performance and standardization of four HCV RNA assays in China: an evaluation of sensitivity, precision, and genotype inclusivity. [PDF]
Yan H +7 more
europepmc +1 more source
ABSTRACT Background and Aims To achieve hepatitis C (HCV) elimination by 2030, testing and treatment must reach people most at risk. Dried blood spot (DBS) testing offers an alternative to venepuncture, suitable for community and prison settings. This study evaluated HCV infection prevalence and treatment initiation among people receiving DBS testing ...
Annabelle Stevens +12 more
wiley +1 more source
Hepatitis C virus testing in infants, a move to early screening by HCV RNA at 2 months of age. [PDF]
Biondi MJ +8 more
europepmc +1 more source
A Turning Point for Hepatitis C Care: Point-of-Care Hepatitis C Virus RNA Authorization as a Critical First Step Toward Integrated Test-and-Treat Models in the United States. [PDF]
Furukawa NW, Kamili S, Wester C.
europepmc +1 more source
Residual HCV-RNA and Elevated Platelet-to-Lymphocyte Ratio Predict Poor Long-Term Outcomes in Patients with Chronic Hepatitis C After Treatment. [PDF]
Wróblewska A +7 more
europepmc +1 more source

